Artificial Intelligence in Aortic Regurgitation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Artificial Intelligence in Aortic Regurgitation — Stella

Home/Aortic Regurgitation Disease/

View on ClinicalTrials.gov

Recruiting

Back to Aortic Regurgitation Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Hong Kong

Division of Cardiology, Department of Medicine and Therapeutics Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, New Territories

Key details

Sponsor

Chinese University of Hong Kong

Collaborators

Semmelweis University, The Prince Charles Hospital

Enrollment target

~540 participants

Started

December 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.